Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase 3 5 Phase 1/2 4 Phase 1 3 Phase NA 2 Phase 2/3 1

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Prostatic Neoplasms 7 Recurrence 6 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Oropharyngeal Neoplasms 3 Melanoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Glioblastoma 3 Gallbladder Neoplasms 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Thyroid Neoplasms 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Mouth Neoplasms 2 Leukemia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Hyperthermia 2

Interventions

Radiation 1 Mitomycin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × Anus Neoplasms × Clear all

NCT05902533 2025-12-18

REDEL

University of Cincinnati

Phase 2/3 Active not recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡